Stocktoria
Envoy Medical, Inc. COCH
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2021-03-02
Envoy Medical, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $241,000 | $225,000 | $316,000 | $237,000 | — |
| R&D expense | $12.5M | $10.2M | $9.0M | $5.0M | — |
| SG&A expense | — | — | $7.3M | $2.6M | — |
| Operating income | -$22.3M | -$19.3M | -$18.4M | -$8.7M | -$5.2M |
| Income tax | — | — | — | $1.5M | — |
| Net income | -$23.8M | -$20.8M | -$29.9M | -$15.9M | -$251,633 |
| EPS (diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | — |
| Operating cash flow | -$18.2M | -$17.9M | -$17.1M | -$8.8M | -$3.2M |
| Free cash flow | -$18.4M | -$18.9M | -$17.2M | -$9.0M | — |
| Cash & equivalents | — | — | $4.2M | $183,000 | $149,845 |
| Inventory | $1.5M | $1.7M | $1.4M | $1.3M | — |
| Total assets | $8.6M | $11.5M | $8.3M | $2.6M | $426.9M |
| Total liabilities | $20.3M | $30.4M | $10.0M | $38.8M | $38.6M |
| Shareholders' equity | -$12.2M | -$18.8M | -$1.8M | -$36.2M | -$45.0M |
Source: SEC EDGAR filings · CIK 0001840877 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.